SCHEMBL1586523

SCHEMBL1586523

CC(=O)C1CC1c1c(F)cccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPK1 P28482 1/20 0.52
GAA P10253 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
POLB P06746 2/20 0.40
SMARCA2 P51531 2/20 0.38
SMARCA4 P51532 2/20 0.38
PBRM1 Q86U86 2/20 0.38
ALOX15 P16050 1/20 0.38
GPR88 Q9GZN0 1/20 0.38
MAPT P10636 1/20 0.37
LDHA P00338 1/20 0.37
LDHB P07195 1/20 0.37
KDM4E B2RXH2 1/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6155358 0.89 HTR2C (0.43) MEN1KMT2AMAPK1ALOX15GPR88
SCHEMBL6155361 0.89 HTR2C (0.43) MEN1KMT2AMAPK1ALOX15GPR88
SCHEMBL6130264 0.89 ALDH1A1 (0.41) MEN1KMT2AMAPK1TSHRSMN1; SMN2
SCHEMBL1586594 0.89 ALDH1A1 (0.41) MEN1KMT2AMAPK1TSHRSMN1; SMN2
SCHEMBL16585100 0.86 MEN1 (0.50) MEN1KMT2AMAPK1GAACYP2C9
SCHEMBL17985242 0.86 MEN1 (0.50) MEN1KMT2AMAPK1GAACYP2C9
SCHEMBL16585271 0.86 MEN1 (0.50) MEN1KMT2AMAPK1GAACYP2C9
SCHEMBL1586522 0.79 MEN1 (0.42) MEN1KMT2AMAPK1CYP3A4CYP2C9
SCHEMBL11926875 0.79 MEN1 (0.42) MEN1KMT2AMAPK1CYP3A4CYP2C9
SCHEMBL16591425 0.76 MEN1 (0.46) MEN1KMT2AMAPK1GAACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488501-B1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2014-04-30 EP disclosed
US-8357635-B2 Microbiocides SYNGENTA CROP PROTECTION LLC (US) 2013-01-22 US disclosed
EP-2488501-A1 NOVEL MICROBIOCIDES Syngenta Participations AG (CH) 2012-08-22 EP disclosed
US-20120202867-A1 NOVEL MICROBIOCIDES SYNGENTA CROP PROTECTION LLC (US) 2012-08-09 US disclosed
WO-2011045355-A1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202867-A1 NOVEL MICROBIOCIDES CD14, FPR1, MPO MEN1 3185/4885KMT2A 4264/4885MAPK1 2608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.